Synthesis and biological evaluation of novel 1-substituted 3-(3-phenoxyprop-1-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors

被引：12
|
作者：
Zheng, Nan [1 ,2 ]
Hao, Qun [1 ]
Lin, Kuaile [1 ]
Pan, Jing [1 ,2 ]
Li, Yingxia [2 ]
Zhou, Weicheng [1 ]
机构：
[1] China State Inst Pharmaceut Ind, Shanghai Key Lab Antiinfect, State Key Lab New Drug & Pharmaceut Proc, Shanghai Inst Pharmaceut Ind, 285 Gebaini Rd, Shanghai 201203, Peoples R China
[2] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 02期
关键词：
BTK inhibitors; 1-Substituted pyrazolo[3,4-d]pyrimidine; Inhibitory activity; B-cell lymphoblastic leukemia; Cytotoxicity; B-CELL; DISCOVERY; IBRUTINIB;
D O I：
10.1016/j.bmcl.2018.11.051
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A new series of 1-substituted pyrazolopyrimidine derivatives were synthesized as potent BTK inhibitors and they were evaluated by enzyme-based assay and anti-proliferation against multiple B-cell lymphoma cell lines in vitro. Among these compounds, 9h exhibited the highest potency against BTK enzyme, with IC50 value of 4.2 nM. In particular, 8 and 9f performed better inhibition against the proliferation of B lymphoma cell lines DOHH2 and WSU-DLCL2 than the clinical drug ibrutinb. In addition, the test toward the normal PBMC cells showed that 8 possessed low cell cytotoxicity. All these explorations indicated that 8 could serve as a valuable anti-tumor agent for B-cell lymphoblastic leukemia treatment.
引用
收藏
页码：225 / 229
页数：5
相关论文
共 50 条
  • [41] Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4′,3′:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors
    Metwally, Nadia Hanafy
    Deeb, Emad Abdullah
    Hasani, Ibrahim Walid
    BMC CHEMISTRY, 2024, 18 (01)
  • [42] GO Nanosheets: Promising Nano Carrier for the S29, 1-(2-Chloro-2-(4-chlorophenyl-ethyl)-N-(4-fluorobenzyl)-1H-pyrazolo[3,4-d] pyrimidin-4-amine, Therapeutic Agent in Neuroblastoma
    Mardente, Stefania
    Aventaggiato, Michele
    Mari, Emanuela
    Francioso, Antonio
    Tafani, Marco
    Mosca, Luciana
    Zicari, Alessandra
    Malyshev, Igor
    Kuznetsova, Larisa
    Valentini, Federica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 14
  • [43] Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
    Mandour, Asmaa A.
    Nassar, Ibrahim F.
    Aal, Mohammed T. Abdel
    Shahin, Mahmoud A. E.
    El-Sayed, Wael A.
    Hegazy, Maghawry
    Yehia, Amr Mohamed
    Ismail, Ahmed
    Hagras, Mohamed
    Elkaeed, Eslam B.
    Refaat, Hanan M.
    Ismail, Nasser S. M.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 1957 - 1973
  • [44] Synthesis of Some Novel 3-Alkyl/aryl-6-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles
    Chen, Xiqing
    Liu, Chenjiang
    Wang, Jide
    Li, Yanping
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2010, 47 (05) : 1225 - 1229
  • [45] Design, Synthesis, and Biological Evaluation of C-2 Substituted 3H-thieno[2,3-d]pyrimidin-4-one Derivatives as Novel FGFR1 Inhibitors
    Guo, Ping
    Xie, Zixin
    Zhang, Huan
    Zhang, Zaikui
    Han, Chao
    Cheng, Donghua
    Lin, Dan
    Zhang, Yuan
    Wang, Xuebao
    Guo, Xin
    Ye, Faqing
    MEDICINAL CHEMISTRY, 2017, 13 (08) : 753 - 760
  • [46] Synthesis and Biological Evaluation of 3-Biphenyl-4-yl-4-phenyl-4H-1,2,4-triazoles as Novel Glycine Transporter 1 Inhibitors
    Sugane, Takashi
    Tobe, Takahiko
    Hamaguchi, Wataru
    Shimada, Itsuro
    Maeno, Kyoichi
    Miyata, Junji
    Suzuki, Takeshi
    Kimizuka, Tetsuya
    Kohara, Atsuyuki
    Morita, Takuma
    Doihara, Hitoshi
    Saita, Kyouko
    Aota, Masaki
    Furutani, Masako
    Shimada, Yoshiaki
    Hamada, Noritaka
    Sakamoto, Shuichi
    Tsukamoto, Shin-ichi
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 387 - 391
  • [47] Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors
    Ali, Sahar A.
    Awad, Samir Mohamed
    Said, Ahmed Mohammed
    Mahgoub, Shahenda
    Taha, Heba
    Ahmed, Naglaa Mohamed
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 847 - 863
  • [48] A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease
    Umar, Tarana
    Shalini, Shruti
    Raza, Md Kausar
    Gusain, Siddharth
    Kumar, Jitendra
    Seth, Prerna
    Tiwari, Manisha
    Hoda, Nasimul
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 175 : 2 - 19
  • [49] Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl) pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT1A receptor and SERT
    Wrobel, Martyna Z.
    Chodkowski, Andrzej
    Dawidowski, Maciej
    Siwek, Agata
    Stachowicz, Katarzyna
    Szewczyk, Bernadeta
    Nowak, Gabriel
    Satala, Grzegorz
    Bojarski, Andrzej J.
    Turlo, Jadwiga
    BIOORGANIC CHEMISTRY, 2023, 141
  • [50] Synthesis and biological evaluation of novel phosphatidylinositol 3-kinase inhibitors: Solubilized 4-substituted benzimidazole analogs of 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474)
    Rewcastle, Gordon W.
    Gamage, Swarna A.
    Flanagan, Jack U.
    Kendall, Jackie D.
    Denny, William A.
    Baguley, Bruce C.
    Buchanan, Christina M.
    Chao, Mindy
    Kestell, Philip
    Kolekar, Sharada
    Lee, Woo-Jeong
    Lill, Claire L.
    Malik, Alisha
    Singh, Ripudaman
    Jamieson, Stephen M. F.
    Shepherd, Peter R.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 64 : 137 - 147
12345